» Articles » PMID: 29311561

Inhibition of RGMa Alleviates Symptoms in a Rat Model of Neuromyelitis Optica

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jan 10
PMID 29311561
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Neuromyelitis optica (NMO) is an autoimmune disease associated with NMO immunoglobulin G (NMO-IgG), an antibody that selectively binds to the aquaporin-4. Here, we established a localized NMO model by injecting NMO-IgG into the spinal cord, and assessed the efficacy of treating its NMO-like symptoms by blocking repulsive guidance molecule-a (RGMa), an axon growth inhibitor. The model showed pathological features consistent with NMO. Systemic administration of humanized monoclonal anti-RGMa antibody delayed the onset and attenuated the severity of clinical symptoms. Further, it preserved astrocytes and reduced inflammatory-cell infiltration and axonal damage, suggesting that targeting RGMa is effective in treating NMO.

Citing Articles

Inhibition of repulsive guidance molecule A ameliorates diabetes-induced cognitive decline and hippocampal neurogenesis impairment in mice.

Uno H, Itokazu T, Yamashita T Commun Biol. 2025; 8(1):263.

PMID: 39972167 PMC: 11840113. DOI: 10.1038/s42003-025-07696-7.


Regulation of Axon Guidance by Slit2 and Netrin-1 Signaling in the Lacrimal Gland of Aqp5 Knockout Mice.

Bai Y, Di G, Ge H, Li B, Zhang K, Zhang D Invest Ophthalmol Vis Sci. 2023; 64(12):27.

PMID: 37707834 PMC: 10506685. DOI: 10.1167/iovs.64.12.27.


Modulation of Microglia M2 Polarization and Alleviation of Hippocampal Neuron Injury By MiR-106b-5p/RGMa in a Mouse Model of Status Epilepticus.

Yu T, Huo L, Lei J, Sun J, Wang H Inflammation. 2022; 45(6):2223-2242.

PMID: 35789312 DOI: 10.1007/s10753-022-01686-1.


Humanized Anti-RGMa Antibody Treatment Promotes Repair of Blood-Spinal Cord Barrier Under Autoimmune Encephalomyelitis in Mice.

Hirata T, Itokazu T, Sasaki A, Sugihara F, Yamashita T Front Immunol. 2022; 13:870126.

PMID: 35784362 PMC: 9241446. DOI: 10.3389/fimmu.2022.870126.


Expression and Clinical Correlation Analysis Between Repulsive Guidance Molecule a and Neuromyelitis Optica Spectrum Disorders.

Tang J, Zeng X, Yang J, Zhang L, Li H, Chen R Front Immunol. 2022; 13:766099.

PMID: 35185873 PMC: 8850277. DOI: 10.3389/fimmu.2022.766099.


References
1.
Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T . Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun. 2009; 386(4):623-7. DOI: 10.1016/j.bbrc.2009.06.085. View

2.
Zhang H, Verkman A . Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica. J Clin Invest. 2013; 123(5):2306-16. PMC: 3635742. DOI: 10.1172/JCI67554. View

3.
Lennon V, Kryzer T, Pittock S, Verkman A, Hinson S . IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005; 202(4):473-7. PMC: 2212860. DOI: 10.1084/jem.20050304. View

4.
Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M . Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009; 66(5):630-43. DOI: 10.1002/ana.21837. View

5.
Hata K, Fujitani M, Yasuda Y, Doya H, Saito T, Yamagishi S . RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J Cell Biol. 2006; 173(1):47-58. PMC: 2063787. DOI: 10.1083/jcb.200508143. View